A phase II study of induction PD-1 blockade in subjects with locally advanced mismatch repair-deficient rectal adenocarcinoma.

被引：0
|
作者：
Cercek, Andrea
Stadler, Zsofia Kinga
Cohen, Jenna L.
Weiss, Jill A.
Lamendola-Essel, Michelle F.
Krishnan, Asha
Yaeger, Rona
Segal, Neil Howard
Connell, Louise Catherine
El Dika, Imane H.
Kemeny, Nancy E.
Saltz, Leonard B.
Smith, Jesse Joshua
Nash, Garrett Michael
Paty, Philip
Garcia-Aguilar, Julio
Weiser, Martin R.
Diaz, Luis A.
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, 1275 York Ave, New York, NY 10021 USA
[3] Weill Cornell Med Coll, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Colorectal Oncol, 1275 York Ave, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Surg, Colorectal Serv, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4123
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study
    Chen, Gong
    Jin, Ying
    Guan, Wen-Long
    Zhang, Rong-Xin
    Xiao, Wei-Wei
    Cai, Pei-Qiang
    Liu, Min
    Lin, Jun-Zhong
    Wang, Fu-Long
    Li, Cong
    Quan, Ting-Ting
    Xi, Shao-Yan
    Zhang, Hui-Zhong
    Pan, Zhi-Zhong
    Wang, Feng
    Xu, Rui-Hua
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (05): : 422 - 431
  • [12] A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer (NIVEC)
    Alsomairi, Amal
    Lee, Jung-Yun
    Lee, Yong Jae
    Cho, Hyun-Woong
    Park, Jeong-Yeol
    Lee, Yoo Young
    Lee, Sung Jong
    Lim, Myong Cheol
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A249 - A249
  • [13] Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer
    Li, Jianxia
    Wu, Cheng
    Hu, Huabin
    Qin, Ge
    Wu, Xueqian
    Bai, Fan
    Zhang, Jianwei
    Cai, Yue
    Huang, Yan
    Wang, Chao
    Yang, Jiaqi
    Luan, Yizhao
    Jiang, Zehang
    Ling, Jiayu
    Wu, Zehua
    Chen, Yaoxu
    Xie, Zhi
    Deng, Yanhong
    CANCER CELL, 2023, 41 (06) : 1152 - +
  • [14] Immune Marker Spatial Distribution and Clinical Outcome after PD-1 Blockade in Mismatch Repair-deficient, Advanced Colorectal Carcinomas
    Saberzadeh-Ardestani, Bahar
    Graham, Rondell P.
    McMahon, Sara
    Ahanonu, Eze
    Shi, Qian
    Williams, Crystal
    Hubbard, Antony
    Zhang, Wenjun
    Muranyi, Andrea
    Yan, Dongyao
    Jin, Zhaohui
    Shanmugam, Kandavel
    Sinicrope, Frank A.
    CLINICAL CANCER RESEARCH, 2023, 29 (20) : 4268 - 4277
  • [15] Neoadjuvant PD-1 blockade in mismatch repair-deficient or microsatellite instability-high, locally advanced and resectable colorectal cancer: A retrospective real-world analysis.
    Lian, Yugui
    Su, Chang
    Zhao, Ruihua
    Lian, Yanbang
    Zhou, Quanbo
    Jin, Shui-Ling
    Guo, Shihao
    Sun, Zhenqiang
    Zhang, Zhiyong
    Wang, Guixian
    Fu, Yang
    Wang, Yunlong
    Yuan, Weitang
    Wan, Xiang-Bo
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 185 - 185
  • [16] PD-1 blockade in neoadjuvant setting of DNA mismatch repair-deficient/microsatellite instability-high colorectal cancer
    Liu, Ding-Xin
    Li, Dan-Dan
    He, Wan
    Ke, Chuan-Feng
    Jiang, Wu
    Tang, Jing-Hua
    Kong, Ling-Heng
    Li, Yuan
    Sui, Qiao-Qi
    Xiao, Bin-Yi
    Li, Wei-Rong
    Hong, Zhi-Gang
    Xu, Rui-Hua
    Pan, Zhi-Zhong
    Zhang, Xiao-Shi
    Ding, Pei-Rong
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [17] Neoadjuvant anti-programmed death 1 (PD-1) therapy in patients (pts) with resectable mismatch repair-deficient (dMMR) locally advanced rectal cancer (LARC): EPOC2201.
    Bando, Hideaki
    Tsukada, Yuichiro
    Taketomi, Akinobu
    Yuki, Satoshi
    Komatsu, Yoshito
    Akiyoshi, Takashi
    Shinozaki, Eiji
    Kanemitsu, Yukihide
    Takashima, Atsuo
    Shiozawa, Manabu
    Shiomi, Akio
    Yamazaki, Kentaro
    Matsuhashi, Nobuhisa
    Hasegawa, Hiroko
    Kato, Takeshi
    Oki, Eiji
    Wakabayashi, Masashi
    Fuse, Nozomu
    Ito, Masaaki
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS226 - TPS226
  • [18] Single-Agent Neoadjuvant Immunotherapy With a PD-1 Antibody in Locally Advanced Mismatch Repair-Deficient or Microsatellite Instability-High Colorectal Cancer
    Pei, Fengyun
    Wu, Jingjing
    Zhao, Yandong
    He, Wan
    Yao, Qijun
    Huang, Meijin
    Huang, Jun
    CLINICAL COLORECTAL CANCER, 2023, 22 (01) : 85 - 91
  • [19] Neoadjuvant immunotherapy for mismatch repair-deficient colon cancer: a phase II study
    Hindson, Jordan
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2024, : 534 - 534
  • [20] Randomized phase II trial of preoperative chemoradiotherapy with or without cetuximab in locally advanced rectal adenocarcinoma.
    McCollum, A. David
    Kocs, Darren M.
    Chadha, Punit
    Monticelli, Michael A.
    Boyd, Thomas E.
    Fain, Jerry Dean
    Kasper, Michael
    Sanchez, James
    Simon, Miklos
    Singh, Paramjeet
    Thummala, Anu
    Vukelja, Svetislava J.
    Wang, Yunfei
    Asmar, Lina
    Richards, Donald A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
12345